Inhibikase Therapeutics, Inc. (IKT) Insider Transactions & Form 4 Activity

Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Inhibikase Therapeutics, Inc. (IKT).

Company Snapshot

Company: Inhibikase Therapeutics, Inc. (IKT)
Ticker: IKT
Market Cap: $219.2M
Latest Price: $1.66
Industry: Biotech & Pharma

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.